News
2019.07.16
Our officer personnel affairs
More
2018.08.08
ImmuniT Research Inc. will participate in BioJapan 2018.
More
2018.04.04
ImmuniT Research Inc. has signed a license agreement with “Sysmex Corporation” regarding exclusive rights that anticipates the effect of immuno-checkpoint inhibitors by blood test.
More
2017.09.25
Licensing of a novel method for evaluation of immune checkpoint inhibitor efficacy prior to treatment initiation
More